LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 6 of 15: Mean cell count and mean growth rate across biological replicate 3. - Dataset (ID:20242)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
BT-20 | CGP60474 | 10.0 | uM | LJP6 | 72 | hr | 1097 | 427 | 3769 | 0.1135 | -0.2506 |
Hs 578T | Omipalisib | 3.33 | uM | LJP6 | 72 | hr | 658 | 436 | 3846 | 0.1135 | -0.0696 |
MCF 10A | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 962 | 1209 | 10605 | 0.1140 | 0.0256 |
Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 658 | 440 | 3846 | 0.1144 | -0.0684 |
MDA-MB-231 | Alvocidib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 517 | 4513 | 0.1145 | -0.2194 |
MDA-MB-231 | GSK1059615 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 518 | 4513 | 0.1148 | -0.2190 |
MDA-MB-231 | WZ3105 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 518 | 4513 | 0.1148 | -0.2189 |
Hs 578T | AT-7519 | 1.11 | uM | LJP6 | 72 | hr | 658 | 442 | 3846 | 0.1149 | -0.0678 |
SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 72 | hr | 1401 | 486 | 4223 | 0.1151 | -0.3245 |
MCF 10A | PHA-793887 | 0.37 | uM | LJP6 | 72 | hr | 962 | 1224 | 10605 | 0.1154 | 0.0272 |
MDA-MB-231 | CGP60474 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 521 | 4513 | 0.1154 | -0.2181 |
MCF 10A | Afatinib | 10.0 | uM | LJP6 | 72 | hr | 962 | 1227 | 10605 | 0.1157 | 0.0275 |
MDA-MB-231 | LDN-193189 | 10.0 | uM | LJP5 | 72 | hr | 1235 | 522 | 4513 | 0.1157 | -0.2178 |
MCF 10A | Geldanamycin | 0.04 | uM | LJP6 | 72 | hr | 962 | 1229 | 10605 | 0.1159 | 0.0277 |
MCF7 | CGP60474 | 10.0 | uM | LJP6 | 72 | hr | 1209 | 474 | 4093 | 0.1160 | -0.2549 |
Hs 578T | AZD 5438 | 3.33 | uM | LJP6 | 72 | hr | 658 | 446 | 3846 | 0.1161 | -0.0664 |
BT-20 | A443654 | 10.0 | uM | LJP6 | 72 | hr | 1097 | 437 | 3769 | 0.1161 | -0.2468 |
Hs 578T | Torin2 | 10.0 | uM | LJP5 | 72 | hr | 658 | 447 | 3846 | 0.1164 | -0.0660 |
MDA-MB-231 | A443654 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 525 | 4513 | 0.1164 | -0.2168 |
MDA-MB-231 | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 525 | 4513 | 0.1165 | -0.2167 |
Hs 578T | Pelitinib | 10.0 | uM | LJP5 | 72 | hr | 658 | 448 | 3846 | 0.1167 | -0.0657 |
Hs 578T | PF477736 | 10.0 | uM | LJP5 | 72 | hr | 658 | 449 | 3846 | 0.1169 | -0.0654 |
MDA-MB-231 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 530 | 4513 | 0.1174 | -0.2154 |
MCF 10A | TWS119 | 10.0 | uM | LJP5 | 72 | hr | 962 | 1247 | 10605 | 0.1176 | 0.0296 |
MCF 10A | Momelotinib | 10.0 | uM | LJP5 | 72 | hr | 962 | 1247 | 10605 | 0.1177 | 0.0296 |